Prudential Financial’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,200
Closed -$58.2K 2526
2025
Q1
$58.2K Buy
16,200
+1,600
+11% +$6.04K ﹤0.01% 2181
2024
Q4
$59.9K Sell
14,600
-7,200
-33% -$25.9K ﹤0.01% 2196
2024
Q3
$67.4K Hold
21,800
﹤0.01% 2614
2024
Q2
$39.7K Buy
21,800
+2,000
+10% +$3.39K ﹤0.01% 2635
2024
Q1
$31.5K Buy
19,800
+9,200
+87% +$17.9K ﹤0.01% 2628
2023
Q4
$21.1K Hold
10,600
﹤0.01% 2615
2023
Q3
$26K Buy
+10,600
New +$26.9K ﹤0.01% 2559

Other funds holding XGN

Prudential Financial's XGN Position: Q2 2025 in Review

Prudential Financial sold out of Exagen (XGN) in Q2 2025, closing a stake of 16,200 shares — an estimated $58.2K sold.

Prudential Financial first reported a position in XGN in Q3 2023 and held it in 7 quarters. The position peaked at $67.4K in Q3 2024. 53 funds tracked by Wall St. Rank hold XGN as of Q2 2025.

  • Prudential Financial reported no remaining Exagen position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 16,200 Exagen shares in Q2 2025, an estimated $58.2K.
  • Prudential Financial first reported a position in Exagen in Q3 2023 and held it in 7 quarters.
  • Prudential Financial's Exagen position peaked at $67.4K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.